Myr5A peptide
Myr5A peptide is an acylated peptide composed of apolipoprotein A1 (ApoA1) analog peptide 5A peptide coupled to the saturated fatty acid myristate. Myr5A peptide self-assembled into lipid nanostructures can be used to encapsulate anthracycline Doxorubicin and Valrubicin (HY-13772) for compound release studies in vitro[1].
Product Specifications
UNSPSC
12352209
Target
Others
Type
Peptides
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/myr5a-peptide.html
Smiles
[{Myr}-Asp-Trp-Leu-Lys-Ala-Phe-Tyr-Asp-Lys-Val-Ala-Glu-Lys-Leu-Lys-Glu-Ala-Phe-Pro-Asp-Trp-Ala-Lys-Ala-Ala-Tyr-Asp-Lys-Ala-Ala-Glu-Lys-Ala-Lys-Glu-Ala-Ala]
Molecular Formula
C211H321N47O57
Molecular Weight
4428.09
References & Citations
[1]Raut S, et al. Probing the assembly of HDL mimetic, drug carrying nanoparticles using intrinsic fluorescence[J]. Journal of Pharmacology and Experimental Therapeutics, 2020, 373 (1) : 113-121.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC428341 20 µg
SLC25A39 (NM_001143780) Human Over-expression Lysate
Sign In for Pricing
View Details 
